Lanoxin PG 50 micrograms/ml Elixir

Product Information *

  • Company:

    Aspen
  • Status:

    No Recent Update
  • Active Ingredients :

    *Additional information is available upon request

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 09 July 2020

File name

Digo_OralSol_IE_S_0.05mg.ml_v5_1594304868.pdf

Reasons for updating

  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 09 July 2020

File name

Digo_OralSol_IE_P_0.05mg-ml_v5_1594304745.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink

Updated on 09 July 2020

File name

Digo_Inj_IE_P_0.25mg-ml_v5_1594304527.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink

Updated on 30 April 2019

File name

Digo_OralSol_IE_S_0.05mg.ml_v4_1556619004.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 22 January 2019

File name

Digo_OralSol_IE_P_0.05mg-ml_v4_1548154015.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 05 February 2018

File name

PIL_9869_472.pdf

Reasons for updating

  • New PIL for new product

Updated on 05 February 2018

Reasons for updating

  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision

Updated on 18 April 2017

Reasons for updating

  • Change to Section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children and adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - dose and frequency
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 08 April 2014

Reasons for updating

  • Change to date of revision
  • Change to MA holder contact details

Updated on 19 November 2013

Reasons for updating

  • Change of active ingredient
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change to dosage and administration
  • Addition of information on alternative format leaflets

Updated on 30 January 2013

Reasons for updating

  • Improved electronic presentation

Updated on 27 May 2011

Reasons for updating

  • Change to marketing authorisation holder

Updated on 12 March 2010

Reasons for updating

  • Change to marketing authorisation holder

Updated on 31 January 2006

Reasons for updating

  • Improved electronic presentation

Updated on 26 May 2005

Reasons for updating

  • New PIL for medicines.ie